ERIC DOBMEIER Insider Trading $SGEN Seagen Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ERIC DOBMEIER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ERIC DOBMEIER. ERIC DOBMEIER is Chief Business Officer in SEATTLE GENETICS INC /WA ($SGEN) and Chief Operating Officer in SEATTLE GENETICS INC /WA ($SGEN) and Sr. VP, Corporate Development in SEATTLE GENETICS INC /WA ($SGEN) and V. P., Corporate Affairs in SEATTLE GENETICS INC /WA ($SGEN) and Vice President, in SEATTLE GENETICS INC /WA ($SGEN) and Director in STEMLINE THERAPEUTICS INC ($STML) and President, CEO in ADURO BIOTECH, INC. ($ADRO) and Director in Adaptive Biotechnologies Corp ($ADPT) and Director in Versartis, Inc. ($VSAR) and Director in Atara Biotherapeutics, Inc. ($ATRA).
ERIC DOBMEIER in Seagen Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ERIC DOBMEIER: Chief Operating Officer, Chief Business Officer, Sr. VP, Corporate Development, V. P., Corporate Affairs, Vice President,
Holdings: 121,153 shares
Current Value: $7,364,891
Latest Transaction: Dec 06 2017
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ERIC DOBMEIER in Seagen Inc.
Sentiment: All, ADPT, ARAV, ATRA, ADRO, SGEN, STML
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.07 | 4,200 | 21,294 | 26,451 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.07 | 3,180 | 16,123 | 30,651 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.07 | 3,600 | 18,252 | 33,831 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.07 | 1,620 | 8,213 | 37,431 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.07 | 1,000 | 5,070 | 39,051 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.07 | 1,000 | 5,070 | 40,051 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.07 | 2,000 | 10,140 | 41,051 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.07 | 1,400 | 7,098 | 43,051 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.07 | 1,900 | 9,633 | 44,451 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 4.45 | 20,000 | 89,000 | 42,618 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.93 | 400 | 4,772 | 3,798 | 4.2 K to 3.8 K (-9.53 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 400 | 2,100 | 4,198 | 3.8 K to 4.2 K (+10.53 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.91 | 200 | 2,382 | 3,798 | 4 K to 3.8 K (-5.00 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 200 | 1,050 | 3,998 | 3.8 K to 4 K (+5.27 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.90 | 300 | 3,570 | 3,798 | 4.1 K to 3.8 K (-7.32 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 300 | 1,575 | 4,098 | 3.8 K to 4.1 K (+7.90 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.89 | 300 | 3,567 | 3,798 | 4.1 K to 3.8 K (-7.32 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 300 | 1,575 | 4,098 | 3.8 K to 4.1 K (+7.90 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.88 | 400 | 4,752 | 3,798 | 4.2 K to 3.8 K (-9.53 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 400 | 2,100 | 4,198 | 3.8 K to 4.2 K (+10.53 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.87 | 300 | 3,561 | 3,798 | 4.1 K to 3.8 K (-7.32 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 300 | 1,575 | 4,098 | 3.8 K to 4.1 K (+7.90 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.86 | 300 | 3,558 | 3,798 | 4.1 K to 3.8 K (-7.32 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 300 | 1,575 | 4,098 | 3.8 K to 4.1 K (+7.90 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.85 | 1,300 | 15,405 | 3,798 | 5.1 K to 3.8 K (-25.50 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 1,300 | 6,825 | 5,098 | 3.8 K to 5.1 K (+34.23 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.84 | 600 | 7,104 | 3,798 | 4.4 K to 3.8 K (-13.64 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 600 | 3,150 | 4,398 | 3.8 K to 4.4 K (+15.80 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.83 | 3,327 | 39,358 | 3,798 | 7.1 K to 3.8 K (-46.69 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 3,327 | 17,467 | 7,125 | 3.8 K to 7.1 K (+87.60 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.82 | 3,373 | 39,869 | 3,798 | 7.2 K to 3.8 K (-47.04 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 3,373 | 17,708 | 7,171 | 3.8 K to 7.2 K (+88.81 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.81 | 1,900 | 22,439 | 3,798 | 5.7 K to 3.8 K (-33.35 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 1,900 | 9,975 | 5,698 | 3.8 K to 5.7 K (+50.03 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.80 | 600 | 7,080 | 3,798 | 4.4 K to 3.8 K (-13.64 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 600 | 3,150 | 4,398 | 3.8 K to 4.4 K (+15.80 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.79 | 800 | 9,432 | 3,798 | 4.6 K to 3.8 K (-17.40 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 800 | 4,200 | 4,598 | 3.8 K to 4.6 K (+21.06 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.78 | 900 | 10,602 | 3,798 | 4.7 K to 3.8 K (-19.16 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 900 | 4,725 | 4,698 | 3.8 K to 4.7 K (+23.70 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.77 | 2,042 | 24,034 | 3,798 | 5.8 K to 3.8 K (-34.97 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 2,042 | 10,721 | 5,840 | 3.8 K to 5.8 K (+53.77 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.76 | 700 | 8,232 | 3,798 | 4.5 K to 3.8 K (-15.56 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 700 | 3,675 | 4,498 | 3.8 K to 4.5 K (+18.43 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.75 | 1,658 | 19,482 | 3,798 | 5.5 K to 3.8 K (-30.39 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 1,658 | 8,705 | 5,456 | 3.8 K to 5.5 K (+43.65 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.74 | 800 | 9,392 | 3,798 | 4.6 K to 3.8 K (-17.40 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 800 | 4,200 | 4,598 | 3.8 K to 4.6 K (+21.06 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.73 | 400 | 4,692 | 3,798 | 4.2 K to 3.8 K (-9.53 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 400 | 2,100 | 4,198 | 3.8 K to 4.2 K (+10.53 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.72 | 400 | 4,688 | 3,798 | 4.2 K to 3.8 K (-9.53 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 400 | 2,100 | 4,198 | 3.8 K to 4.2 K (+10.53 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.71 | 1,800 | 21,078 | 3,798 | 5.6 K to 3.8 K (-32.15 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 1,800 | 9,450 | 5,598 | 3.8 K to 5.6 K (+47.39 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.70 | 2,784 | 32,573 | 3,798 | 6.6 K to 3.8 K (-42.30 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 2,784 | 14,616 | 6,582 | 3.8 K to 6.6 K (+73.30 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.69 | 1,664 | 19,452 | 3,798 | 5.5 K to 3.8 K (-30.47 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 1,664 | 8,736 | 5,462 | 3.8 K to 5.5 K (+43.81 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.68 | 2,052 | 23,967 | 3,798 | 5.9 K to 3.8 K (-35.08 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 2,052 | 10,773 | 5,850 | 3.8 K to 5.9 K (+54.03 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.67 | 300 | 3,501 | 3,798 | 4.1 K to 3.8 K (-7.32 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 300 | 1,575 | 4,098 | 3.8 K to 4.1 K (+7.90 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.66 | 400 | 4,664 | 3,798 | 4.2 K to 3.8 K (-9.53 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 400 | 2,100 | 4,198 | 3.8 K to 4.2 K (+10.53 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.65 | 200 | 2,330 | 3,798 | 4 K to 3.8 K (-5.00 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 200 | 1,050 | 3,998 | 3.8 K to 4 K (+5.27 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.64 | 400 | 4,656 | 3,798 | 4.2 K to 3.8 K (-9.53 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 400 | 2,100 | 4,198 | 3.8 K to 4.2 K (+10.53 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.63 | 800 | 9,304 | 3,798 | 4.6 K to 3.8 K (-17.40 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 800 | 4,200 | 4,598 | 3.8 K to 4.6 K (+21.06 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.62 | 1,100 | 12,782 | 3,798 | 4.9 K to 3.8 K (-22.46 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 1,100 | 5,775 | 4,898 | 3.8 K to 4.9 K (+28.96 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.61 | 900 | 10,449 | 3,798 | 4.7 K to 3.8 K (-19.16 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 900 | 4,725 | 4,698 | 3.8 K to 4.7 K (+23.70 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.60 | 1,200 | 13,920 | 3,798 | 5 K to 3.8 K (-24.01 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 1,200 | 6,300 | 4,998 | 3.8 K to 5 K (+31.60 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.59 | 1,400 | 16,226 | 3,798 | 5.2 K to 3.8 K (-26.93 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 1,400 | 7,350 | 5,198 | 3.8 K to 5.2 K (+36.86 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.58 | 400 | 4,632 | 3,798 | 4.2 K to 3.8 K (-9.53 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 400 | 2,100 | 4,198 | 3.8 K to 4.2 K (+10.53 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.57 | 1,100 | 12,727 | 3,798 | 4.9 K to 3.8 K (-22.46 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 1,100 | 5,775 | 4,898 | 3.8 K to 4.9 K (+28.96 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.56 | 600 | 6,936 | 3,798 | 4.4 K to 3.8 K (-13.64 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 600 | 3,150 | 4,398 | 3.8 K to 4.4 K (+15.80 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.54 | 282 | 3,254 | 3,798 | 4.1 K to 3.8 K (-6.91 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 282 | 1,481 | 4,080 | 3.8 K to 4.1 K (+7.42 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.53 | 500 | 5,765 | 3,798 | 4.3 K to 3.8 K (-11.63 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 500 | 2,625 | 4,298 | 3.8 K to 4.3 K (+13.16 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.52 | 500 | 5,760 | 3,798 | 4.3 K to 3.8 K (-11.63 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 500 | 2,625 | 4,298 | 3.8 K to 4.3 K (+13.16 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.51 | 518 | 5,962 | 3,798 | 4.3 K to 3.8 K (-12.00 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 518 | 2,720 | 4,316 | 3.8 K to 4.3 K (+13.64 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.50 | 4,700 | 54,050 | 3,798 | 8.5 K to 3.8 K (-55.31 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 4,700 | 24,675 | 8,498 | 3.8 K to 8.5 K (+123.75 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.60 | 1,300 | 15,080 | 3,798 | 5.1 K to 3.8 K (-25.50 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 1,300 | 6,825 | 5,098 | 3.8 K to 5.1 K (+34.23 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.73 | 400 | 4,692 | 3,798 | 4.2 K to 3.8 K (-9.53 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 400 | 2,100 | 4,198 | 3.8 K to 4.2 K (+10.53 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.72 | 100 | 1,172 | 3,798 | 3.9 K to 3.8 K (-2.57 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 100 | 525 | 3,898 | 3.8 K to 3.9 K (+2.63 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.71 | 300 | 3,513 | 3,798 | 4.1 K to 3.8 K (-7.32 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 300 | 1,575 | 4,098 | 3.8 K to 4.1 K (+7.90 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.70 | 1,300 | 15,210 | 3,798 | 5.1 K to 3.8 K (-25.50 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 1,300 | 6,825 | 5,098 | 3.8 K to 5.1 K (+34.23 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.69 | 600 | 7,014 | 3,798 | 4.4 K to 3.8 K (-13.64 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 600 | 3,150 | 4,398 | 3.8 K to 4.4 K (+15.80 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.68 | 3,480 | 40,646 | 3,798 | 7.3 K to 3.8 K (-47.82 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 3,480 | 18,270 | 7,278 | 3.8 K to 7.3 K (+91.63 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.67 | 1,300 | 15,171 | 3,798 | 5.1 K to 3.8 K (-25.50 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 1,300 | 6,825 | 5,098 | 3.8 K to 5.1 K (+34.23 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.66 | 2,220 | 25,885 | 3,798 | 6 K to 3.8 K (-36.89 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 2,220 | 11,655 | 6,018 | 3.8 K to 6 K (+58.45 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.65 | 1,400 | 16,310 | 3,798 | 5.2 K to 3.8 K (-26.93 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 1,400 | 7,350 | 5,198 | 3.8 K to 5.2 K (+36.86 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.64 | 1,800 | 20,952 | 3,798 | 5.6 K to 3.8 K (-32.15 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 1,800 | 9,450 | 5,598 | 3.8 K to 5.6 K (+47.39 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.61 | 400 | 4,644 | 3,798 | 4.2 K to 3.8 K (-9.53 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 400 | 2,100 | 4,198 | 3.8 K to 4.2 K (+10.53 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.59 | 183 | 2,121 | 3,798 | 4 K to 3.8 K (-4.60 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 183 | 961 | 3,981 | 3.8 K to 4 K (+4.82 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.59 | 717 | 8,310 | 3,798 | 4.5 K to 3.8 K (-15.88 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.07 | 717 | 3,635 | 4,515 | 3.8 K to 4.5 K (+18.88 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.58 | 4,200 | 48,636 | 3,798 | 8 K to 3.8 K (-52.51 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.07 | 4,200 | 21,294 | 7,998 | 3.8 K to 8 K (+110.58 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.57 | 3,180 | 36,793 | 3,798 | 7 K to 3.8 K (-45.57 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.07 | 3,180 | 16,123 | 6,978 | 3.8 K to 7 K (+83.73 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.56 | 3,600 | 41,616 | 3,798 | 7.4 K to 3.8 K (-48.66 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.07 | 3,600 | 18,252 | 7,398 | 3.8 K to 7.4 K (+94.79 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.55 | 1,620 | 18,711 | 3,798 | 5.4 K to 3.8 K (-29.90 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.07 | 1,620 | 8,213 | 5,418 | 3.8 K to 5.4 K (+42.65 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.54 | 1,000 | 11,540 | 3,798 | 4.8 K to 3.8 K (-20.84 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.07 | 1,000 | 5,070 | 4,798 | 3.8 K to 4.8 K (+26.33 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.53 | 1,000 | 11,530 | 3,798 | 4.8 K to 3.8 K (-20.84 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.07 | 1,000 | 5,070 | 4,798 | 3.8 K to 4.8 K (+26.33 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.52 | 2,000 | 23,040 | 3,798 | 5.8 K to 3.8 K (-34.49 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.07 | 2,000 | 10,140 | 5,798 | 3.8 K to 5.8 K (+52.66 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.51 | 1,400 | 16,114 | 3,798 | 5.2 K to 3.8 K (-26.93 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.07 | 1,400 | 7,098 | 5,198 | 3.8 K to 5.2 K (+36.86 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.50 | 1,900 | 21,850 | 3,798 | 5.7 K to 3.8 K (-33.35 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.07 | 1,900 | 9,633 | 5,698 | 3.8 K to 5.7 K (+50.03 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.50 | 20,000 | 230,000 | 3,798 | 23.8 K to 3.8 K (-84.04 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 4.45 | 20,000 | 89,000 | 23,798 | 3.8 K to 23.8 K (+526.59 %) |
| Aug 30 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | A | 10.29 | 85,446 | 879,239 | 85,446 | |
| Aug 30 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | A | 10.29 | 4,554 | 46,861 | 4,554 | |
| May 30 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | A | 10.20 | 42,136 | 429,787 | 42,136 | |
| May 30 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | A | 10.20 | 7,864 | 80,213 | 7,864 | |
| Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Option Exercise | M | 5.25 | 11,470 | 60,218 | 59,383 | |
| Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Option Exercise | M | 5.25 | 700 | 3,675 | 70,853 | |
| Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Option Exercise | M | 5.25 | 4,135 | 21,709 | 71,553 | |
| Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Option Exercise | M | 5.25 | 4,300 | 22,575 | 75,688 |